NELSON FUENTEBELLA: Open Payments
NPI 1295075760 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,673 in 79 payments from 18 companies in 2025. Trend: 2023 $3,902 · 2024 $2,681 · 2025 $1,673
Food & beverage: $1,673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $394 |
| BIOTRONIK NRO, Inc. | 11 | $226 |
| Collegium Pharmaceutical, Inc. | 14 | $196 |
| VERTEX PHARMACEUTICALS INCORPORATED | 7 | $189 |
| IBSA Pharma Inc. | 6 | $96 |
| Lundbeck LLC | 4 | $89 |
| SPR Therapeutics, Inc | 2 | $80 |
| Azurity Pharmaceuticals, Inc. | 3 | $70 |
| Virtus Pharmaceuticals LLC | 2 | $53 |
| TerSera Therapeutics LLC | 2 | $49 |
Products named: QULIPTA, Prospera, Belbuca, JOURNAVX, UBRELVY, Tirosint, VYEPTI, SPRINT PNS System.
Industry payments across CA — which companies pay providers there.
